In 2023, the use of antidepressant medicine in Sweden stood at 117.4 units (Defined Daily Dosage) per thousand persons per day. In 2024, a rise to 120.0 units is observed, forecasted to increase further to 122.8 units in 2025, 125.4 units in 2026, 128.1 units in 2027, and 130.7 units in 2028. This indicates a consistent year-on-year growth: approximately 2.3% from 2024 to 2025, 2.1% from 2025 to 2026, 2.2% from 2026 to 2027, and 2.0% from 2027 to 2028. Over the five years from 2023 to 2028, the compound annual growth rate (CAGR) averages around 2.18%.
Future trends to watch for:
• Increasing awareness and reduction of stigma around mental health may further drive the usage of antidepressants.
• Advances in medical research and development of more effective antidepressants could influence prescription patterns.
• Socio-economic factors, including the impact of unemployment rates and societal stressors, might also play a significant role in future trends.
